Clinical Trial Update: Can DFN-15 Terminate Migraine With Allodynia? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for DFN-15 evaluating its ability to terminate migraine with allodynia (migraine with and without aura).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allodynia
• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• DFN-15 (DFN-15)

Snippet

Sponsor: Hartford Hospital | Conditions: Migraine With Aura, Migraine Without Aura | Phase 2 | Status: COMPLETED